Australia markets closed

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0650+0.0010 (+1.56%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 129.48M
Enterprise value 93.85M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.98
Price/book (mrq)2.54
Enterprise value/revenue 9.07
Enterprise value/EBITDA -9.34

Trading information

Stock price history

Beta (5Y monthly) 2.98
52-week change 3-69.52%
S&P500 52-week change 323.23%
52-week high 30.2400
52-week low 30.0630
50-day moving average 30.0740
200-day moving average 30.1047

Share statistics

Avg vol (3-month) 31.75M
Avg vol (10-day) 32.17M
Shares outstanding 52.02B
Implied shares outstanding 62.05B
Float 81.76B
% held by insiders 114.30%
% held by institutions 114.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -185.47%
Operating margin (ttm)-270.00%

Management effectiveness

Return on assets (ttm)-27.58%
Return on equity (ttm)-42.36%

Income statement

Revenue (ttm)10.47M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-15.40%
Gross profit (ttm)N/A
EBITDA -22.88M
Net income avi to common (ttm)-19.5M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.91M
Total cash per share (mrq)0.02
Total debt (mrq)1.27M
Total debt/equity (mrq)2.50%
Current ratio (mrq)7.00
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-12.63M
Levered free cash flow (ttm)-14.65M